Vanguard Group’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $434M | Buy |
9,542,944
+118,135
| +1% | +$5.46M | 0.01% | 1141 |
|
|
2025
Q3 | $420M | Buy |
9,424,809
+172,062
| +2% | +$8.23M | 0.01% | 1151 |
|
|
2025
Q2 | $446M | Buy |
9,252,747
+375,564
| +4% | +$16.3M | 0.01% | 1093 |
|
|
2025
Q1 | $353M | Buy |
8,877,183
+244,735
| +3% | +$10.3M | 0.01% | 1194 |
|
|
2024
Q4 | $398M | Buy |
8,632,448
+74,977
| +0.9% | +$3.36M | 0.01% | 1179 |
|
|
2024
Q3 | $398M | Sell |
8,557,471
-50,061
| -0.6% | -$2.28M | 0.01% | 1172 |
|
|
2024
Q2 | $364M | Buy |
8,607,532
+183,119
| +2% | +$8.03M | 0.01% | 1151 |
|
|
2024
Q1 | $373M | Buy |
8,424,413
+110,938
| +1% | +$5.06M | 0.01% | 1156 |
|
|
2023
Q4 | $383M | Buy |
8,313,475
+78,623
| +1% | +$3.34M | 0.01% | 1140 |
|
|
2023
Q3 | $354M | Buy |
8,234,852
+132,088
| +2% | +$6.16M | 0.01% | 1105 |
|
|
2023
Q2 | $387M | Buy |
8,102,764
+126,893
| +2% | +$6.12M | 0.01% | 1083 |
|
|
2023
Q1 | $388M | Buy |
7,975,871
+50,007
| +0.6% | +$2.54M | 0.01% | 1054 |
|
|
2022
Q4 | $419M | Buy |
7,925,864
+122,642
| +2% | +$6.05M | 0.01% | 978 |
|
|
2022
Q3 | $342M | Buy |
7,803,222
+127,916
| +2% | +$6.32M | 0.01% | 1057 |
|
|
2022
Q2 | $384M | Buy |
7,675,306
+83,901
| +1% | +$4.09M | 0.01% | 1016 |
|
|
2022
Q1 | $394M | Buy |
7,591,405
+169,668
| +2% | +$8.76M | 0.01% | 1115 |
|
|
2021
Q4 | $437M | Buy |
7,421,737
+116,262
| +2% | +$6.67M | 0.01% | 1088 |
|
|
2021
Q3 | $400M | Buy |
7,305,475
+158,069
| +2% | +$8.8M | 0.01% | 1123 |
|
|
2021
Q2 | $367M | Buy |
7,147,406
+106,911
| +2% | +$5.52M | 0.01% | 1206 |
|
|
2021
Q1 | $364M | Buy |
7,040,495
+22,927
| +0.3% | +$1.26M | 0.01% | 1167 |
|
|
2020
Q4 | $393M | Buy |
7,017,568
+23,064
| +0.3% | +$1.23M | 0.01% | 1023 |
|
|
2020
Q3 | $388M | Buy |
6,994,504
+25,835
| +0.4% | +$1.34M | 0.01% | 887 |
|
|
2020
Q2 | $316M | Sell |
6,968,669
-107,288
| -2% | -$4.8M | 0.01% | 994 |
|
|
2020
Q1 | $312M | Buy |
7,075,957
+311,370
| +5% | +$12.2M | 0.01% | 880 |
|
|
2019
Q4 | $242M | Sell |
6,764,587
-34,870
| -0.5% | -$1.3M | 0.01% | 1279 |
|
|
2019
Q3 | $238M | Buy |
6,799,457
+131,385
| +2% | +$5.05M | 0.01% | 1228 |
|
|
2019
Q2 | $287M | Buy |
6,668,072
+194,546
| +3% | +$8.06M | 0.01% | 1134 |
|
|
2019
Q1 | $279M | Buy |
6,473,526
+30,740
| +0.5% | +$1.24M | 0.01% | 1133 |
|
|
2018
Q4 | $235M | Buy |
6,442,786
+193,003
| +3% | +$7.17M | 0.01% | 1149 |
|
|
2018
Q3 | $251M | Buy |
6,249,783
+120,829
| +2% | +$4.83M | 0.01% | 1228 |
|
|
2018
Q2 | $235M | Buy |
6,128,954
+45,957
| +0.8% | +$1.69M | 0.01% | 1245 |
|
|
2018
Q1 | $208M | Buy |
6,082,997
+188,647
| +3% | +$6.62M | 0.01% | 1270 |
|
|
2017
Q4 | $193M | Buy |
5,894,350
+155,255
| +3% | +$5.35M | 0.01% | 1325 |
|
|
2017
Q3 | $192M | Buy |
5,739,095
+29,966
| +0.5% | +$1.03M | 0.01% | 1291 |
|
|
2017
Q2 | $203M | Buy |
5,709,129
+371,753
| +7% | +$12.6M | 0.01% | 1223 |
|
|
2017
Q1 | $164M | Buy |
+5,337,376
| New | +$165M | 0.01% | 1352 |
|
Other funds holding QGEN
Vanguard Group's QGEN Position: Q4 2025 in Review
Vanguard Group increased its Qiagen (QGEN) stake by 1.3% in Q4 2025, buying an estimated $5.46M and bringing the position to 9,542,944 shares worth $434M. The position accounts for 0.01% of the portfolio, ranked #1141.
Vanguard Group first reported a position in QGEN in Q1 2017 and has held it in 36 quarters since. The position peaked at $446M in Q2 2025. 320 funds tracked by Wall St. Rank hold QGEN as of Q4 2025.
- Vanguard Group held 9,542,944 shares of Qiagen worth $434M as of Q4 2025.
- Vanguard Group bought 118,135 Qiagen shares in Q4 2025, an estimated $5.46M.
- Qiagen made up 0.01% of Vanguard Group's portfolio in Q4 2025, its #1141 holding.
- Vanguard Group first reported a position in Qiagen in Q1 2017 and has held it in 36 quarters since.
- Vanguard Group's Qiagen position peaked at $446M in Q2 2025.
- 320 funds tracked by Wall St. Rank held Qiagen as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.